Healthcare / Medical Instruments & SuppliesFrankfurt
$210.00
-2.00 (-0.94%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $60.1M · quality 49.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$746M
P/E
12.2x
↓EV/EBITDA
4.0x
↓ROE
5.2%
↑Gross Margin
60.4%
↑Debt/Equity
0.30
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.0%
FCF CAGR
—
FCF margin
1.2%
FCF / Net income
0.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.45B · net income $61.2M · FCF $28.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.45B | $2.45B | $2.41B | $2.35B | $2.31B |
| Net Income | $61.2M | $61.2M | $108.5M | $28.4M | $36.1M |
| EBITDA | $234.8M | $234.8M | $248.8M | $167.8M | $167.3M |
| EPS | 17.23 | 17.23 | 30.53 | 8.00 | 10.18 |
| Gross Margin | 60.4% | 60.4% | 59.8% | 56.0% | 56.7% |
| Operating Margin | 4.0% | 4.0% | 4.7% | 1.4% | 1.3% |
| Net Margin | 2.5% | 2.5% | 4.5% | 1.2% | 1.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.30 | 0.30 | 0.25 | 0.23 | 0.23 |
| Current Ratio | 2.22 | 2.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $28.4M | $28.4M | $60.1M | $117.7M | $-119.2M |
| Returns | |||||
| ROE | 5.2% | 5.2% | 9.4% | 2.7% | 3.4% |
| Valuation | |||||
| P/E | 12.20 | 12.20 | 7.24 | 25.00 | 21.81 |
| EV/EBITDA | 4.00 | 4.00 | 3.67 | 4.82 | 5.57 |
| P/B | 0.63 | 0.63 | 0.68 | 0.67 | 0.73 |
| Growth & Yield | |||||
| Revenue Growth | 1.7% | 1.7% | 2.3% | 1.8% | — |
| EPS Growth | -43.6% | -43.6% | 281.6% | -21.4% | — |
| Dividend Yield | 3.8% | 3.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
2.6%
EPS terminal req.
$18.63
Spread vs growth
-46.2%
5Y implied EPS CAGR
5.5%
EPS terminal req.
$22.55
Spread vs growth
-49.1%
10Y implied EPS CAGR
7.7%
EPS terminal req.
$36.31
Spread vs growth
-51.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.9%
Start / end P/E
8.2x → 12.2x
EPS bridge
30.53 → 17.23
Residual
-21.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.